Humanization and characterization of the anti-HLA-DR antibody 1D10. (Q48350859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Humanization and characterization of the anti-HLA-DR antibody 1D10 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

S A Kostelny

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Y Tso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Vasquez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B H Jorgensen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

W C Hall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

G J Weiner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

556-565

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477560%20AND%20SRC:MED&resulttype=core&format=json

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

9 November 2019

cites work

1 reference

Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody

21 January 2018

1 reference

Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas

21 January 2018

1 reference

A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies

21 January 2018

1 reference

NMR-derived model for a peptide-antibody complex.

21 January 2018

1 reference

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase

21 January 2018

1 reference

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

21 January 2018

1 reference

A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies

21 January 2018

1 reference

A humanized antibody that binds to the interleukin 2 receptor

21 January 2018

1 reference

Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10.

21 January 2018

1 reference

Mechanisms involved in the inhibition of growth of a human B lymphoma cell line, B104, by anti-MHC class II antibodies

21 January 2018

1 reference

Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes

21 January 2018

1 reference

Lymphocyte programmed cell death is mediated via HLA class II DR.

21 January 2018

1 reference

Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis

21 January 2018

1 reference

A unique cell surface antigen identifying lymphoid malignancies of B cell origin

21 January 2018

1 reference

Critical Lym-1 binding residues on polymorphic HLA-DR molecules

21 January 2018

1 reference

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

21 January 2018

1 reference

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

21 January 2018

1 reference

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

Preparation of a bispecific F(ab')2 targeted to the human IL-2 receptor

21 January 2018

1 reference

Molecular dynamics of native protein. I. Computer simulation of trajectories

21 January 2018

1 reference

HLA-DRα chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes

21 January 2018

1 reference

Structural motifs involved in human IgG antibody effector functions

21 January 2018

1 reference